MyFinsight
Home
Blog
About
Net loss
attributable to catheter...
-$2,555K
Deemed contribution on
extinguishment of preferred...
-$740K
Net loss
attributable to catheter...
-$3,295K
(35.51%↑ Y/Y)
Less net gain
attributable to...
-$11K
(96.85%↑ Y/Y)
US
$210K
(21.39%↑ Y/Y)
Europe
$60K
(53.85%↑ Y/Y)
Net loss
-$3,306K
(39.43%↑ Y/Y)
Income tax benefit
-$312K
(67.16%↑ Y/Y)
Unrealized gains and losses
on marketable...
$378K
Service
$749K
Product
$270K
Change in fair value of
deferred consideration
$318K
Interest income
$4K
(33.33%↑ Y/Y)
Loss from operations
before income tax...
-$3,618K
(43.54%↑ Y/Y)
Total other income
(expense), net
$337K
(119.57%↑ Y/Y)
Revenues
$1,019K
Interest
expense-Nonrelated Party
$161K
Loss on debt
extinguishment
-$105K
Other expenses, net
-$54K
(-5300.00%↓ Y/Y)
Interest
expense-Related Party
$43K
Operating loss
-$3,955K
(15.60%↑ Y/Y)
Gross profit
$98K
(-50.51%↓ Y/Y)
Total cost of revenues
$921K
(6478.57%↑ Y/Y)
Total operating
expenses
$4,053K
(-17.01%↓ Y/Y)
Service
$899K
Product
$22K
Selling, general and
administrative
$3,911K
(35.75%↑ Y/Y)
Research and development
$142K
(-8.39%↓ Y/Y)
Back
Back
Income Statement
Catheter Precision, Inc. (VTAK)
Catheter Precision, Inc. (VTAK)
source: myfinsight.com